Assetmark Inc. boosted its stake in shares of Medical Properties Trust, Inc. (NYSE:MPW) by 59.4% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 254,623 shares of the real estate investment trust’s stock after buying an additional 94,837 shares during the quarter. Assetmark Inc. owned 0.06% of Medical Properties Trust worth $4,441,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds also recently modified their holdings of the company. Cullen Frost Bankers Inc. lifted its stake in shares of Medical Properties Trust by 70.9% during the second quarter. Cullen Frost Bankers Inc. now owns 1,832 shares of the real estate investment trust’s stock valued at $32,000 after buying an additional 760 shares during the period. Manchester Financial Inc. purchased a new position in shares of Medical Properties Trust during the second quarter valued at approximately $33,000. Cascade Investment Advisors Inc. purchased a new position in shares of Medical Properties Trust during the second quarter valued at approximately $35,000. Princeton Global Asset Management LLC purchased a new position in shares of Medical Properties Trust during the first quarter valued at approximately $37,000. Finally, Icon Wealth Partners LLC acquired a new position in Medical Properties Trust during the first quarter worth approximately $42,000. Institutional investors own 71.33% of the company’s stock.
NYSE MPW traded down $0.06 during trading hours on Friday, reaching $19.77. 2,070,807 shares of the company traded hands, compared to its average volume of 3,466,315. The company has a 50 day moving average of $19.04 and a two-hundred day moving average of $18.29. The company has a current ratio of 8.00, a quick ratio of 8.00 and a debt-to-equity ratio of 0.99. Medical Properties Trust, Inc. has a 12 month low of $13.98 and a 12 month high of $20.02. The stock has a market capitalization of $8.82 billion, a PE ratio of 14.43, a PEG ratio of 3.78 and a beta of 0.53.
The company also recently disclosed a quarterly dividend, which was paid on Thursday, October 10th. Investors of record on Thursday, September 12th were given a $0.26 dividend. The ex-dividend date was Wednesday, September 11th. This is an increase from Medical Properties Trust’s previous quarterly dividend of $0.25. This represents a $1.04 annualized dividend and a yield of 5.26%. Medical Properties Trust’s dividend payout ratio (DPR) is currently 75.91%.
Several equities analysts recently commented on the stock. SunTrust Banks upped their price target on shares of Medical Properties Trust from $20.00 to $21.00 and gave the stock a “buy” rating in a research report on Tuesday, August 27th. Deutsche Bank raised shares of Medical Properties Trust from a “hold” rating to a “buy” rating in a research report on Monday, July 29th. ValuEngine lowered shares of Medical Properties Trust from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. JPMorgan Chase & Co. set a $21.00 price objective on shares of Medical Properties Trust and gave the stock a “buy” rating in a research report on Wednesday, September 4th. Finally, Berenberg Bank began coverage on shares of Medical Properties Trust in a research report on Thursday, September 12th. They issued a “buy” rating and a $22.00 price objective for the company. One analyst has rated the stock with a sell rating, three have given a hold rating and seven have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $19.95.
In related news, Director G Steven Dawson bought 7,476 shares of the stock in a transaction on Thursday, August 8th. The shares were purchased at an average price of $18.07 per share, with a total value of $135,091.32. Following the purchase, the director now owns 76,302 shares in the company, valued at $1,378,777.14. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO R Steven Hamner sold 77,500 shares of Medical Properties Trust stock in a transaction that occurred on Wednesday, September 25th. The stock was sold at an average price of $19.43, for a total transaction of $1,505,825.00. Following the completion of the transaction, the chief financial officer now directly owns 1,235,457 shares in the company, valued at approximately $24,004,929.51. The disclosure for this sale can be found here. Over the last quarter, insiders sold 247,500 shares of company stock worth $4,586,725. 1.18% of the stock is currently owned by insiders.
Medical Properties Trust Profile
Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.
Featured Article: Different Types of Derivatives
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.